Tappia Paramjit S, Lopez Rhea, Fitzpatrick-Wong Shirley, Ramjiawan Bram
Asper Clinical Research Institute & Albrechtsen Research Centre, St. Boniface Hospital, Winnipeg, MB R2H 2A6, Canada.
Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0T6, Canada.
Rev Cardiovasc Med. 2023 Apr 17;24(4):111. doi: 10.31083/j.rcm2404111. eCollection 2023 Apr.
Vitamin D is now believed to have a significant role in cardiac signal transduction and regulation of gene expression, and thus influences normal cardiomyocyte function. It has been reported to provide cardioprotection through its anti-inflammatory, anti-apoptotic and anti-fibrotic actions; and to prevent cardiac remodeling, -handling defects, and abnormal electrophysiological patterns. A vitamin D deficient state has been associated in the pathogenesis of heart failure; however, while many clinical studies report a benefit of vitamin D to heart function, other clinical studies are inconsistent with these findings. These uncertainties have led to a discord in the recommendation of vitamin D supplementation for the treatment of heart failure or as a preventive agent in patients deemed to be at risk for cardiac dysfunction. Accordingly, this article is intended to describe some of the mechanisms/sites of action of vitamin D in different animal models of heart failure, as well as to review the clinical observations and challenges in the interpretation and understanding of the clinical relevance of vitamin D in relation to heart function.
目前认为维生素D在心脏信号转导和基因表达调控中发挥着重要作用,从而影响正常心肌细胞功能。据报道,它通过抗炎、抗凋亡和抗纤维化作用提供心脏保护;并预防心脏重塑、钙处理缺陷和异常电生理模式。维生素D缺乏状态与心力衰竭的发病机制有关;然而,虽然许多临床研究报告了维生素D对心脏功能有益,但其他临床研究与这些发现不一致。这些不确定性导致在推荐补充维生素D用于治疗心力衰竭或作为被认为有心脏功能障碍风险患者的预防药物方面存在分歧。因此,本文旨在描述维生素D在不同心力衰竭动物模型中的一些作用机制/位点,并回顾在解释和理解维生素D与心脏功能临床相关性方面的临床观察和挑战。